Noninvasive tests in the post–liver transplantation setting
✍ Scribed by Xavier Forns; José A. Carrión; Miquel Navasa; Juan Carlos García-Pagan; Miquel Bruguera; Jaume Bosch
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 73 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21131
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hepatocellular carcinoma (HCC) is a frequent complication and leading cause of mortality among patients with cirrhosis. In the setting of advanced liver disease, many patients with HCC are not candidates for hepatic resection due to inadequate functional hepatic reserve and the risk of postoperative
Anxiety is a common experience in chronic illness but for many with end-stage liver disease it is also associated with the stress of waiting for a donor organ to become available. Quality of life, work, family and social roles are all impaired and these losses may also contribute to depression. This
Posttransplantation recurrence of hepatitis C virus infection is a universal phenomenon with a highly variable natural history. 2. Approximately 10% to 25% of hepatitis C virusinfected recipients of liver allografts will develop cirrhosis within 5 years' after transplantation. 3. The 1-year actuaria